Markus Harboe Olsen1,2, Britt Morthorst3, Anne Katrine Pagsberg3,4, Michella Heinrichsen3, Bo Møhl5, Lotte Rubæk6, Johan Bjureberg7,8, Olivia Simonsson8, Jane Lindschou9, Christian Gluud9,10, Janus Christian Jakobsen9,10. 1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. oel@oelfam.com. 2. Department of Neuroanaesthesiology, Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. oel@oelfam.com. 3. Research Unit, Child and Adolescent Mental Health Services, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. 4. Department of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, Denmark. 5. Department of Communication and Psychology, Aalborg University, Aalborg, Denmark. 6. Team of Self-Injury, Child and Adolescent Mental Health Services, Copenhagen, Denmark. 7. Department of Psychology, Stanford University, Stanford, CA, USA. 8. Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden. 9. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. 10. Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Abstract
BACKGROUND: Non-suicidal self-injury (NSSI) has a lifetime prevalence of 17% in adolescents in the general population and up to 74% in adolescents with psychiatric disorders. NSSI is one of the most important predictors of later suicidal behaviour and death by suicide. The TEENS feasibility trial was initiated to assess the feasibility and safety of Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA) as an add-on to treatment as usual in 13-17-year-old patients with NSSI referred to the Child and Adolescent Mental Health Services. METHODS: The TEENS feasibility trial is a randomised clinical trial with a parallel-group design. The trial intervention is an 11-week online therapy which is tested as an add-on to treatment as usual versus treatment as usual. The primary feasibility outcomes are the fraction of participants who (1) completed 12 weeks of follow-up interview or assessment, (2) consented to inclusion and randomisation out of all eligible participants, and (3) were compliant with the experimental intervention, assessed as completion of at least six out of eleven modules in the programme. Since this is a feasibility trial, we did not predefine a required sample size. The exploratory clinical outcome, the frequency of NSSI episodes, assessed using Deliberate Self-Harm Inventory - Youth version (DSHI-Y), at the end of intervention, is planned to be the future primary outcome in a larger pragmatic definitive randomised clinical trial. After completion of the feasibility trial, blinded data will be analysed by two independent statisticians blinded to the intervention, where 'A' and 'B' refer to the two groups. A third party will compare these reports, and discrepancies will be discussed. The statistical report with the analyses chosen for the manuscript is being tracked using a version control system, and both statistical reports will be published as a supplementary material. Based on the final statistical report, two blinded conclusions will be drawn by the steering group. DISCUSSION: We present a pre-defined statistical analysis plan for the TEENS feasibility trial, which limits bias, p-hacking, data-driven interpretations. This statistical analysis plan is accompanied by a pre-programmed version-controlled statistical report with simulated data, which increases transparency and reproducibility. TRIAL REGISTRATION: ClinicalTrials.gov NCT04243603 . Registered on 28 January 2020.
RCT Entities:
BACKGROUND: Non-suicidal self-injury (NSSI) has a lifetime prevalence of 17% in adolescents in the general population and up to 74% in adolescents with psychiatric disorders. NSSI is one of the most important predictors of later suicidal behaviour and death by suicide. The TEENS feasibility trial was initiated to assess the feasibility and safety of Internet-based Emotion Regulation Individual Therapy for Adolescents (ERITA) as an add-on to treatment as usual in 13-17-year-old patients with NSSI referred to the Child and Adolescent Mental Health Services. METHODS: The TEENS feasibility trial is a randomised clinical trial with a parallel-group design. The trial intervention is an 11-week online therapy which is tested as an add-on to treatment as usual versus treatment as usual. The primary feasibility outcomes are the fraction of participants who (1) completed 12 weeks of follow-up interview or assessment, (2) consented to inclusion and randomisation out of all eligible participants, and (3) were compliant with the experimental intervention, assessed as completion of at least six out of eleven modules in the programme. Since this is a feasibility trial, we did not predefine a required sample size. The exploratory clinical outcome, the frequency of NSSI episodes, assessed using Deliberate Self-Harm Inventory - Youth version (DSHI-Y), at the end of intervention, is planned to be the future primary outcome in a larger pragmatic definitive randomised clinical trial. After completion of the feasibility trial, blinded data will be analysed by two independent statisticians blinded to the intervention, where 'A' and 'B' refer to the two groups. A third party will compare these reports, and discrepancies will be discussed. The statistical report with the analyses chosen for the manuscript is being tracked using a version control system, and both statistical reports will be published as a supplementary material. Based on the final statistical report, two blinded conclusions will be drawn by the steering group. DISCUSSION: We present a pre-defined statistical analysis plan for the TEENS feasibility trial, which limits bias, p-hacking, data-driven interpretations. This statistical analysis plan is accompanied by a pre-programmed version-controlled statistical report with simulated data, which increases transparency and reproducibility. TRIAL REGISTRATION: ClinicalTrials.gov NCT04243603 . Registered on 28 January 2020.
Authors: Joan Rosenbaum Asarnow; Giovanna Porta; Anthony Spirito; Graham Emslie; Greg Clarke; Karen Dineen Wagner; Benedetto Vitiello; Martin Keller; Boris Birmaher; James McCracken; Taryn Mayes; Michele Berk; David A Brent Journal: J Am Acad Child Adolesc Psychiatry Date: 2011-06-11 Impact factor: 8.829
Authors: Sarah Vigerland; Fabian Lenhard; Marianne Bonnert; Maria Lalouni; Erik Hedman; Johan Ahlen; Ola Olén; Eva Serlachius; Brjánn Ljótsson Journal: Clin Psychol Rev Date: 2016-09-20
Authors: Johan Bjureberg; Hanna Sahlin; Clara Hellner; Erik Hedman-Lagerlöf; Kim L Gratz; Jonas Bjärehed; Jussi Jokinen; Matthew T Tull; Brjánn Ljótsson Journal: BMC Psychiatry Date: 2017-12-28 Impact factor: 3.630
Authors: Johan Bjureberg; Hanna Sahlin; Erik Hedman-Lagerlöf; Kim L Gratz; Matthew T Tull; Jussi Jokinen; Clara Hellner; Brjánn Ljótsson Journal: BMC Psychiatry Date: 2018-10-11 Impact factor: 3.630